Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2021-02-04 Sale |
2021-02-05 4:41 pm |
Epizyme Inc. | EPZM | Agarwal Shefali Chief Medical Officer |
969 | $11.21 | $10,862 | 104,341 (Direct) |
View |
| 2021-02-04 Sale |
2021-02-05 4:40 pm |
Epizyme Inc. | EPZM | TOMBESI PAOLO Chief Financial Officer |
1,021 | $11.21 | $11,445 | 53,465 (Direct) |
View |
| 2021-02-04 Sale |
2021-02-05 4:40 pm |
Epizyme Inc. | EPZM | Beaulieu Joseph Corporate Controller |
227 | $11.21 | $2,545 | 13,431 (Direct) |
View |
| 2021-02-04 Sale |
2021-02-05 4:36 pm |
Epizyme Inc. | EPZM | Ros Matthew See Remarks |
894 | $11.21 | $10,022 | 83,188 (Direct) |
View |
| 2021-02-04 Sale |
2021-02-05 4:32 pm |
Epizyme Inc. | EPZM | Vakiener Victoria Chief Commercial Officer |
817 | $11.21 | $9,159 | 52,685 (Direct) |
View |
| 2021-01-25 Sale |
2021-01-27 8:44 pm |
Epizyme Inc. | EPZM | Bazemore Robert B President & CEO |
6,069 | $11.41 | $69,247 | 248,367 (Direct) |
View |
| 2021-01-25 Sale |
2021-01-27 8:42 pm |
Epizyme Inc. | EPZM | Ros Matthew See Remarks |
2,872 | $11.41 | $32,770 | 55,957 (Direct) |
View |
| 2021-01-25 Sale |
2021-01-27 8:42 pm |
Epizyme Inc. | EPZM | Vakiener Victoria Chief Commercial Officer |
599 | $11.41 | $6,835 | 27,982 (Direct) |
View |
| 2021-01-25 Sale |
2021-01-27 8:38 pm |
Epizyme Inc. | EPZM | Agarwal Shefali Chief Medical Officer |
2,872 | $11.41 | $32,770 | 75,727 (Direct) |
View |
| 2020-12-03 Sale |
2020-12-07 07:00 am |
Epizyme Inc. | EPZM | Agarwal Shefali Chief Medical Officer |
2,522 | $13.54 | $34,148 | 76,089 (Direct) |
View |
| 2020-11-11 Purchase |
2020-11-13 07:05 am |
Epizyme Inc. | EPZM | GOLDFISCHER CARL Director |
5,000 | $12.07 | $60,350 | 3,385,951 (Indirect Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2021-02-01 Option Award |
2021-02-02 9:12 pm |
N/A 2031-01-31 |
Epizyme Inc. | EPZM | Agarwal Shefali Chief Medical Officer |
170,718 | $0 | 246,445 (Direct) |
View |
| 2021-02-01 Option Award |
2021-02-02 9:09 pm |
N/A 2031-01-31 |
Epizyme Inc. | EPZM | Bazemore Robert B President & CEO |
504,943 | $0 | 753,310 (Direct) |
View |
| 2021-02-01 Option Award |
2021-02-02 9:08 pm |
N/A 2031-01-31 |
Epizyme Inc. | EPZM | Beaulieu Joseph Corporate Controller |
19,250 | $0 | 25,208 (Direct) |
View |
| 2021-02-01 Option Award |
2021-02-02 9:07 pm |
N/A 2031-01-31 |
Epizyme Inc. | EPZM | TOMBESI PAOLO Chief Financial Officer |
150,280 | $0 | 178,725 (Direct) |
View |
| 2021-02-01 Option Award |
2021-02-02 9:05 pm |
N/A 2031-01-31 |
Epizyme Inc. | EPZM | Vakiener Victoria Chief Commercial Officer |
147,274 | $0 | 175,256 (Direct) |
View |
| 2021-02-01 Option Award |
2021-02-02 9:05 pm |
N/A 2031-01-31 |
Epizyme Inc. | EPZM | Ros Matthew See Remarks |
162,303 | $0 | 218,260 (Direct) |
View |
| 2021-02-01 Option Award |
2021-02-02 9:01 pm |
N/A 2031-01-31 |
Epizyme Inc. | EPZM | Kutok Jeffery Chief Scientific Officer |
165,308 | $0 | 192,720 (Direct) |
View |
Ownership(A) |
2021-01-27 8:31 pm |
N/A N/A |
Epizyme Inc. | EPZM | Vakiener Victoria Chief Commercial Officer |
0 | $0 | 28,581 (Direct) |
View |
| 2020-12-31 Option Award |
2021-01-05 08:32 am |
N/A N/A |
Epizyme Inc. | EPZM | Conroy Kevin T Director |
1,024 | $10.86 | 9,559 (Direct) |
View |
| 2020-12-31 Option Award |
2021-01-05 08:15 am |
N/A N/A |
Epizyme Inc. | EPZM | MOTT DAVID M Director |
2,158 | $10.86 | 195,142 (Direct) |
View |
| 2020-09-30 Option Award |
2020-10-01 4:58 pm |
N/A N/A |
Epizyme Inc. | EPZM | MOTT DAVID M Director |
1,965 | $11.93 | 192,984 (Direct) |
View |
| 2020-09-30 Option Award |
2020-10-01 4:56 pm |
N/A N/A |
Epizyme Inc. | EPZM | Conroy Kevin T Director |
933 | $11.93 | 8,535 (Direct) |
View |
| 2020-09-22 Option Award |
2020-09-28 4:15 pm |
N/A 2030-09-21 |
Epizyme Inc. | EPZM | MOTT DAVID M Director |
50,000 | $0 | 50,000 (Direct) |
View |
Ownership |
2020-09-28 4:15 pm |
N/A N/A |
Epizyme Inc. | EPZM | Vakiener Victoria Chief Commercial Officer |
0 | $0 | 208,424 (Direct) |
View |
| 2020-08-19 Exercise |
2020-08-21 4:15 pm |
N/A N/A |
Epizyme Inc. | EPZM | TOMBESI PAOLO Chief Financial Officer |
7,055 | $0 | 48,068 (Direct) |
View |
| 2020-08-20 Tax Withholding |
2020-08-21 4:15 pm |
N/A N/A |
Epizyme Inc. | EPZM | TOMBESI PAOLO Chief Financial Officer |
2,091 | $12.55 | 48,068 (Direct) |
View |